3-{2-([5,6]-咪唑-1,10-邻菲咯啉)]}-3′-甲酸-2,2’-联吡啶的合成和晶体结构

Synthesis and crystal structure of 2-{3-(1H-Imdazo[4,5-f] [1,10] phenanthrolin-2-yl)pyridin-2-yl}nicotinic acid

以1,10-邻菲咯啉为原料,经三步反应生成了标题化合物,化合物经1H NMR,MS和X-射线单晶衍射表征.结果表明,化合物晶体为单斜晶系,空间群,P21/c,a=1.24828(16)nm,b=1.18534(15)nm,c=1.37542(16)nm,α=90.00°,β=109.268(4)°,γ=90.00°,V=1.9211(4)nm^(3),Z=4,Mr=418.41,Dc=1.440g.cm^(-3),μ=0.097mm^(-1),F(000)=856,R_(1)=0.0633,wR_(2)=0.1803.CCDC:728109.

A novel compound of 2-{3-(^(1)H-imdazo[4,5-f][1,10]phenanthrolin-2-yl)pyridin-2-yl}nicotinic acid was synthesized from 1,10-phenanthrolin through three-step reactions.The compounds were characterized by 1H NMR and MS.The experimental result of X-ray single crystal diffraction analysis revealed that the title compound belongs to monocline system with space groupP21/c,a=1.24828(16)nm,b=1.18534(15)nm,c=1.37542(16)nm,α=90.00°,β=109.268(4)°,γ=90.00°,V=1.9211(4)nm^(3),Z=4,Mr=418.41,Dc=1.440g·cm^(-3),μ=0.097mm^(-1),F(000)=856,R_(1)=0.0633,wR_(2)=0.1803.